<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="98">
  <stage>Registered</stage>
  <submitdate>1/08/2005</submitdate>
  <approvaldate>5/08/2005</approvaldate>
  <actrnumber>ACTRN12605000090617</actrnumber>
  <trial_identification>
    <studytitle>Activity, Diet and Blood Pressure Trial</studytitle>
    <scientifictitle>A randomised phase III study to evaluate the effects of a lifestyle program in the treatment of hypertension to lower blood pressure and decrease antihypertensive drug needs.</scientifictitle>
    <utrn />
    <trialacronym>ADAPT</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Hypertension</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Hypertension</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Behavioural program promoting weight loss, a low-sodium DASH-type diet, high in fish, increased physical activity &amp; reduced alcohol intake with 4 months intervention and follow-up at 1 and 3 years after completion of the intervention.</interventions>
    <comparator />
    <control>Active</control>
    <interventioncode>Lifestyle</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Blood pressure</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Requirements for antihypertensive drugs</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Lipids</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Glucose/insulin</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Cognitive responses</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Qualitative responses elicited in focus groups</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>BMI&gt;25 kg/m2, treated with one or two antihypertensive drugs for at least 3 months.</inclusivecriteria>
    <inclusiveminage>40</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Clinic BP &gt; 160/90 mm Hg; consumption &gt; 2 fish meals or 4 fish oil capsules per week; alcohol intake &gt; 4 standard drinks/day for women and 6 standard drinks/day for men; drug- or insulin-treated diabetes; chronic renal failure (serum creatinine&gt;120 umol/L); chronic liver disease; symptomatic cardiovascular disease &lt; 3 months; other chronic debilitating disease; the use of antihypertensive drugs for indications other than hypertension, such as the use of beta blockers for arrhythmias</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Central allocation by statistician</concealment>
    <sequence>Computer generated random numbers</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Control group received usual care. None of the options under</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/01/2001</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype />
    <primarysponsorname>None</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NH&amp;MRC, FRDC</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>None</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Intervention and 1-year follow-up have been completed.  Further 2-year follow-up is in progress.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of Western Australia School of Medicine &amp; Pharmacology</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Valerie Burke</name>
      <address>School of Medicine &amp; Pharmacology
University of Western Australia
GPO Box X2213
Perth WA 6847</address>
      <phone>+61 8 92240276</phone>
      <fax>+61 8 92240246</fax>
      <email>vburke@cyllene.uwa.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>LJ Beilin</name>
      <address>School of Medicine &amp; Pharmacology
University of Western Australia
GPO Box X2213
Perth WA 6847</address>
      <phone>+61 8 92240258</phone>
      <fax>+61 8 92240246</fax>
      <email>lbeilin@cyllene.uwa.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>